This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ziegler, A. Articles by Rémy, C. Search for Related Content PubMed PubMed Citation Articles by Ziegler, A. Articles by Rémy, C.

High Glycolytic Activity in Rat Glioma Demonstrated in Vivo by Correlation Peak ¹H Magnetic Resonance Imaging¹

Unité mixte Institut National de la Santé et de la Recherche Médicale/Université Joseph Fourier: Unité 438 "RMN Bioclinique," Laboratoire de Recherche Correspondant du Commissariat à l’Energie Atomique, Centre Hospitalier Universitaire BP 217, 38043 Grenoble, France [A. Z., M. D., C. R.], and Physikalisches Institut V, Universität Würzburg, 97074 Würzburg, Germany [M. v. K.]

High-grade brain tumors are known to have a high rate of glucose (Glc) consumption. Postmortem measurements have suggested that Glc content in experimental brain tumors is relatively low. We used magnetic resonance spectroscopy to investigate this, in vivo, in the brains of seven rats bearing intracerebral C6 gliomas. We combined the high spectral resolution allowed by two-dimensional proton nuclear magnetic resonance with spatial encoding by magnetic field gradient pulses to obtain in vivo maps of Glc, alanine, hypotaurine, aspartate, phosphoethanolamine, Glu/Gln, N-acetylaspartate (NAA), phosphocreatine/creatine (PCr/Cr), choline-containing compounds, and lactate (Lac) (some of which are involved in energy metabolism). Compared with normal brain tissue, the main differences found in the gliomas were that Glc, NAA, PCr/Cr, and aspartate concentrations were much lower, whereas concentrations of alanine, hypotaurine, phosphoethanolamine, and Lac were higher, whatever the extent of necrosis. A striking observation is the similarity of the NAA and Glc images: the concentrations of both metabolites are lower in the tumor than they are in the contralateral brain. If Glc was completely absent from the tumor tissue, and if the residual Glc level was due only to a partial volume effect like that for NAA, a neuronal marker, the ratio [Glc]_tumor/[Glc]_{contralateral tissue}, should be similar to that found for NAA. The ratio for Glc was 0.48 ± 0.22 (± SD; n = 6), a ratio similar to that found for PCr/Cr (0.50 ± 0.19) but significantly higher than that obtained for NAA (0.29 ± 0.07). This observation indicates that a measurable Glc concentration is still present in the tumor tissue. Intense glycolysis in tumor cells may explain the increased production of Lac and alanine and decreased amount of Glc. These nuclear magnetic resonance measurements of metabolite concentrations are complementary to positron emission tomography, which measures Glc consumption.

This article has been cited by other articles:

				R. L. Derr, X. Ye, M. U. Islas, S. Desideri, C. D. Saudek, and S. A. Grossman Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma J. Clin. Oncol., March 1, 2009; 27(7): 1082 - 1086. [Abstract] [Full Text] [PDF]

				V. Garcia-Escudero, R. Gargini, and M. Izquierdo Glioma Regression In vitro and In vivo by a Suicide Combined Treatment Mol. Cancer Res., March 1, 2008; 6(3): 407 - 417. [Abstract] [Full Text] [PDF]

				B. Drogat, P. Auguste, D. T. Nguyen, M. Bouchecareilh, R. Pineau, J. Nalbantoglu, R. J. Kaufman, E. Chevet, A. Bikfalvi, and M. Moenner IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo Cancer Res., July 15, 2007; 67(14): 6700 - 6707. [Abstract] [Full Text] [PDF]

				Y.-K. Shin, B. C. Yoo, H. J. Chang, E. Jeon, S.-H. Hong, M.-S. Jung, S.-J. Lim, and J.-G. Park Down-regulation of Mitochondrial F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance Cancer Res., April 15, 2005; 65(8): 3162 - 3170. [Abstract] [Full Text] [PDF]

				J. M. Cuezva, M. Krajewska, M. L. de Heredia, S. Krajewski, G. Santamaria, H. Kim, J. M. Zapata, H. Marusawa, M. Chamorro, and J. C. Reed The Bioenergetic Signature of Cancer: A Marker of Tumor Progression Cancer Res., November 15, 2002; 62(22): 6674 - 6681. [Abstract] [Full Text] [PDF]

				L. A. Kunz-Schughart and J. P. Freyer Phosphorous metabolites and steady-state energetics of transformed fibroblasts during three-dimensional growth Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1287 - C1297. [Abstract] [Full Text] [PDF]